OUR MISSION
Cofactor Genomics is a Predictive Immune Modeling company that uses RNA to diagnose disease. We’ve worked alongside the world’s largest life-sciences and pharmaceutical companies to develop unique technologies and software that use RNA to inform disease, and improve patient selection.
Our team of experts brings decades of collective experience working in the Technology Development Group at the Genome Center at Washington University in St. Louis, Missouri.
OUR TEAM
-
Jarret Glasscock, PhD Founder and CEO
As lead of the Computational Biology Group at the Genome Center, Dr. Glasscock led a team of scientists to characterize and publish key NIH funded sequencing projects. Dr. Glasscock left his faculty position in the department of genetics and part of the Genome Center’s Technology Development Group to found Cofactor Genomics.
-
Jon Armstrong CSO
Jon Armstrong spent 8 years in the Technology Development Group at The Genome Institute at Washington University. In this role, he was instrumental in the design and development of molecular tools for interrogating and characterizing the structure and sequence of DNA and RNA.
-
Dave Messina COO
Dr. David Messina has spent the last 20 years working in computational biology and genetics. He worked on the Human Genome Project at Washington University in Saint Louis, mapped disease genes at the University of Chicago, and earned his PhD in computational biology in Stockholm, Sweden. As COO at Cofactor Genomics, he oversees daily operations and leads regulatory strategy.
-
Eric Duncavage, MD Medical DirectorBoard Certified Clinical Diagnostic Pathologist – Dr. Eric Duncavage co-directs clinical assay development at Washington University. He is a member of the Clinical Laboratory Standards Institute (CLSI) for sequencing-based clinical diagnostics. He also trains fellows and residents in molecular diagnostics – Informatics – Molecular Oncology
SUPPORTED BY
Cofactor is supported by passionate, visionary teams and individuals. Including…
